Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter studyFumihiko Urabe, Takahiro Kimura, Koichi Aikawa et al.|Japanese Journal of Clinical Oncology|2024Cited by 22
Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective studyShuhei Hara, Takahiro Kimura, Keiichiro Mori et al.|International Journal of Clinical Oncology|2024Cited by 9
Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective studyFumihiko Urabe, Takahiro Kimura, Hirokazu Kagawa et al.|Prostate International|2024Cited by 6
Evaluation of Optimal Sequential Treatment Patterns and Clinical Outcomes in Patients With Advanced Urothelial Carcinoma Treated With First‐Line Platinum‐Based Chemotherapy: A Multicenter Collaborative StudyFumihiko Urabe, Kojiro Tashiro, Yu Imai et al.|International Journal of Urology|2025Cited by 5
Clinical features of medication‐related osteonecrosis of the jaw in prostate cancer managementYuma Goto, Fumihiko Urabe, Juria Nakano et al.|British Journal of Urology|2025Cited by 4